Cervical Cancer - Treatment Options, Symptoms, Causes & Diagnosis from MedifocusHealth

Cervical Cancer > What Your Doctor is Reading About Cervical Cancer > Review Articles

Review Articles

1. Topotecan in the management of cervical cancer.

Author: Randall-Whitis LM; Monk BJ;
Institution: Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of California, Irvine, 101 The City Dr South, Bldg 56, Suite 210, Orange, CA 92868, USA. lrandall@uci.edu
Journal: Expert Opin Pharmacother. 2007 Feb;8(2):227-36.
Abstract URL: Click here to view abstract

2. Surgery insight: radical vaginal trachelectomy as a method of fertility preservation for cervical cancer.

Author: Beiner ME; Covens A;
Institution: Gynecologic Oncology Division, University of Toronto, Toronto, ON, Canada.
Journal: Nat Clin Pract Oncol. 2007 Jun;4(6):353-61.
Abstract URL: Click here to view abstract

3. Management of metastatic cervical cancer: review of the literature.

Author: Long HJ 3rd;
Institution: Department of Oncology, Mayo Clinic College of Medicine, Rochester, MN, USA. long.harry@mayo.edu
Journal: J Clin Oncol. 2007 Jul 10;25(20):2966-74.
Abstract URL: Click here to view abstract

4. Impact of the human papilloma vaccine on cervical cancer.

Author: Chan JK; Berek JS;
Institution: Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Stanford University School of Medicine, Stanford Cancer Center, Stanford, CA 94305, USA.
Journal: J Clin Oncol. 2007 Jul 10;25(20):2975-82.
Abstract URL: Click here to view abstract

5. Sentinel lymph node detection in early stage uterine cervix carcinoma: a systematic review.

Author: van de Lande J; Torrenga B; Raijmakers PG; Hoekstra OS; van Baal MW; Brolmann HA; Verheijen RH;
Institution: Department of Obstetrics and Gynecology, Vrije Universiteit Medical Center, P.O. Box 7057, The Netherlands. j.vandelande@vumc.nl
Journal: Gynecol Oncol. 2007 Sep;106(3):604-13. Epub 2007 Jul 12.
Abstract URL: Click here to view abstract

6. Vaccines against human papillomavirus: perspectives for controlling cervical cancer.

Author: Garcia Carranca A; Galvan SC;
Institution: Laboratory of Virus and Cancer, Instituto de Investigaciones Biomedicas, Universidad Nacional Autonoma de Mexico. carranca@biomedicas.unam.mx
Journal: Expert Rev Vaccines. 2007 Aug;6(4):497-510.
Abstract URL: Click here to view abstract

7. The development and future of oligonucleotide-based therapies for cervical cancer.

Author: Gu W; Putral LN; Irving A; McMillan NA;
Institution: University of Queensland, Diamantina Institute for Cancer, Immunology and Molecular Medicine, Cancer Biology Programme, Brisbane, QLD 4072, Australia.
Journal: Curr Opin Mol Ther. 2007 Apr;9(2):126-31.
Abstract URL: Click here to view abstract

8. Advances in primary and secondary interventions for cervical cancer: human papillomavirus prophylactic vaccines and testing.

Author: Wheeler CM;
Institution: Department of Molecular Genetics and Microbiology, University of New Mexico Health Sciences Center, House of Prevention Epidemiology, Building 191, 1816 Sigma Chi Road, Albuquerque, NM 87131, USA. cwheeler@salud.unm.edu
Journal: Nat Clin Pract Oncol. 2007 Apr;4(4):224-35.
Abstract URL: Click here to view abstract

9. Review of current knowledge on HPV vaccination: an appendix to the European Guidelines for Quality Assurance in Cervical Cancer Screening.

Author: Arbyn M; Dillner J;
Institution: Unit of Cancer Epidemiology, Scientific Institute of Public Health, Brussels, Belgium. marc.arbyn@iph.fgov.be
Journal: J Clin Virol. 2007 Mar;38(3):189-97. Epub 2007 Jan 25.
Abstract URL: Click here to view abstract

10. Therapeutic human papillomavirus DNA vaccination strategies to control cervical cancer.

Author: Wu TC;
Institution: Department of Pathology, The Johns Hopkins Medical Institutions, Baltimore, MD 21231, USA. wutc@jhmi.edu
Journal: Eur J Immunol. 2007 Feb;37(2):310-4.
Abstract URL: Click here to view abstract

11. A public health approach to cervical cancer control: considerations of screening and vaccination strategies.

Author: Goldie S;
Institution: Department of Health Policy and Management, Program in Health Descision Science, Boston, MA 02115, USA. sue_goldie@harvard.edu
Journal: Int J Gynaecol Obstet. 2006 Nov;94 Suppl 1:S95-105.
Abstract URL: Click here to view abstract

12. HPV vaccines: the beginning of the end for cervical cancer.

Author: Leggatt GR; Frazer IH;
Institution: Diamantina Institute for Cancer, Immunology and Metabolic Medicine, The University of Queensland, Princess Alexandra Hospital, Woolloongabba, Queensland 4102, Australia.
Journal: Curr Opin Immunol. 2007 Apr;19(2):232-8. Epub 2007 Feb 12.
Abstract URL: Click here to view abstract

13. Human papillomavirus vaccine: a new chance to prevent cervical cancer.

Author: Monk BJ; Mahdavi A;
Institution: Division of Gynecologic Oncology, Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange 92868-3298, USA.
Journal: Recent Results Cancer Res. 2007;174:81-90.
Abstract URL: Click here to view abstract

14. Clinical inquiries. What's the best treatment for CIN 2 or 3?

Author: Lozeau AM; Schrager S; Lowrie R; Huber T;
Institution: Department of Family Medicine, University of Wisconsin, Madison, USA.
Journal: J Fam Pract. 2007 Aug;56(8):650-3.

15. Prophylactic vaccination against human papillomavirus infection and disease in women: a systematic review of randomized controlled trials.

Author: Rambout L; Hopkins L; Hutton B; Fergusson D;
Institution: Department of Pharmacy, The Ottawa Hospital, Ottawa, Ont. lrambout@ottawahospital.on.ca
Journal: CMAJ. 2007 Aug 28;177(5):469-79. Epub 2007 Aug 1.
Abstract URL: Click here to view abstract

16. Therapeutic human papillomavirus vaccines: current clinical trials and future directions.

Author: Hung CF; Ma B; Monie A; Tsen SW; Wu TC;
Institution: The Johns Hopkins University School of Medicine, Department of Pathology, CRBII 309, 1550 Orleans Street, Baltimore, Maryland 21231, USA.
Journal: Expert Opin Biol Ther. 2008 Apr;8(4):421-39.
Abstract URL: Click here to view abstract

17. Obesity and screening for breast, cervical, and colorectal cancer in women: a review.

Author: Cohen SS; Palmieri RT; Nyante SJ; Koralek DO; Kim S; Bradshaw P; Olshan AF;
Institution: Department of Epidemiology, University of North Carolina, Chapel Hill, NC 27599, USA. sarahcohen@unc.edu
Journal: Cancer. 2008 May 1;112(9):1892-904.
Abstract URL: Click here to view abstract

18. Diagnostic accuracy of tests for lymph node status in primary cervical cancer: a systematic review and meta-analysis.

Author: Selman TJ; Mann C; Zamora J; Appleyard TL; Khan K;
Institution: Department of Reproductive and Child Health, University of Birmingham, Birmingham Women's Hospital, Birmingham, United Kingdom. taraselman@blueyonder.co.uk
Journal: CMAJ. 2008 Mar 25;178(7):855-62.
Abstract URL: Click here to view abstract

19. Cervical cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.

Author: Haie-Meder C; Morice P; Castiglione M;
Institution: Department of Radiology, Villejuif, France.
Journal: Ann Oncol. 2008 May;19 Suppl 2:ii17-8.

20. The human papillomavirus vaccine in Canada.

Author: Morris SK; Nguyen CK;
Institution: Division of Infectious Diseases, The Hospital for Sick Children and The University of Toronto, Toronto, ON. shaun.morris@utoronto.ca
Journal: Can J Public Health. 2008 Mar-Apr;99(2):114-6.
Abstract URL: Click here to view abstract

21. Human papillomavirus and cervical disease in adolescents.

Author: Guido R;
Institution: Magee Women's Hospital, Pittsburgh, Pennsylvania, USA. rguido@mail.magee.edu
Journal: Clin Obstet Gynecol. 2008 Jun;51(2):290-305.
Abstract URL: Click here to view abstract

22. Molecular targeted agents combined with chemo-radiation in the treatment of locally advanced cervix cancer.

Author: Herrera FG; Vidal L; Oza A; Milosevic M; Fyles A;
Institution: Department of Radiation Oncology, Princess Margaret Hospital, 610 University Ave. Toronto, Ontario, M5G2M9, Canada.
Journal: Rev Recent Clin Trials. 2008 May;3(2):111-20.
Abstract URL: Click here to view abstract

23. The disparity of cervical cancer in diverse populations.

Author: Downs LS; Smith JS; Scarinci I; Flowers L; Parham G;
Institution: University of Minnesota, Dept of OB/GYN and Women's Health, 420 Delaware Street, 8395 SE, MMC 395 Mayo, Minneapolis, MN 55455, USA. downs008@umn.edu
Journal: Gynecol Oncol. 2008 May;109(2 Suppl):S22-30.
Abstract URL: Click here to view abstract

24. The current and future role of screening in the era of HPV vaccination.

Author: Myers E; Huh WK; Wright JD; Smith JS;
Institution: Division of Clinical and Epidemiological Research, Department of Obstetrics and Gynecology, DUMC 3279, 244 Baker House, Duke University Medical Center, Durham, NC 27710, USA. Myers008@mc.duke.edu
Journal: Gynecol Oncol. 2008 May;109(2 Suppl):S31-9.
Abstract URL: Click here to view abstract

25. Persistent human papillomavirus infection and cervical neoplasia: a systematic review and meta-analysis.

Author: Koshiol J; Lindsay L; Pimenta JM; Poole C; Jenkins D; Smith JS;
Institution: Cancer Prevention Fellowship Program, Division of Cancer Prevention, National Cancer Institute, Bethesda, MD 20892-7236, USA. koshiolj@mail.nih.gov
Journal: Am J Epidemiol. 2008 Jul 15;168(2):123-37. Epub 2008 May 15.
Abstract URL: Click here to view abstract

26. Classification of radical hysterectomy.

Author: Querleu D; Morrow CP;
Institution: Department of Surgery, Institut Claudius Regaud, University Paul Sabatier, Toulouse, France. querleu.denis@claudiusregaud.fr
Journal: Lancet Oncol. 2008 Mar;9(3):297-303.
Abstract URL: Click here to view abstract

27. Venous thromboembolism in cervical cancer.

Author: Barbera L; Thomas G;
Institution: Department of Radiation Oncology, University of Toronto, Toronto, Ontario, Canada.
Journal: Lancet Oncol. 2008 Jan;9(1):54-60.
Abstract URL: Click here to view abstract

28. The sentinel concept in patients with cervical cancer.

Author: Schneider A;
Institution: Department of Gynecology and Gynecologic Oncology, Charite, Berlin, Germany. achim.schneider@charite.de
Journal: J Surg Oncol. 2007 Sep 15;96(4):337-41.
Abstract URL: Click here to view abstract

29. Human papillomavirus and cervical cancer.

Author: Schiffman M; Castle PE; Jeronimo J; Rodriguez AC; Wacholder S;
Institution: Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20892, USA. schiffmm@mail.nih.gov
Journal: Lancet. 2007 Sep 8;370(9590):890-907.
Abstract URL: Click here to view abstract

30. The serum assay of tumour markers in the prognostic evaluation, treatment monitoring and follow-up of patients with cervical cancer: a review of the literature.

Author: Gadducci A; Tana R; Cosio S; Genazzani AR;
Institution: Department of Procreative Medicine, Division of Gynecology and Obstetrics, University of Pisa, Via Roma 56, Pisa 56127, Italy. a.gadducci@obgyn.med.unipi.it
Journal: Crit Rev Oncol Hematol. 2008 Apr;66(1):10-20. Epub 2007 Oct 26.
Abstract URL: Click here to view abstract

31. Cervical and endometrial cancer during pregnancy.

Author: Kehoe S;
Institution: The Women's Centre, John Radcliffe Hospital, Headington, Oxford, UK.
Journal: Recent Results Cancer Res. 2008;178:69-74.

32. Management of cervical cancer: summary of SIGN guidelines.

Author: James RM; Cruickshank ME; Siddiqui N;
Institution: Scottish Intercollegiate Guidelines Network (SIGN), 28 Thistle Street, Edinburgh EH2 1EN.
Journal: BMJ. 2008 Jan 5;336(7634):41-3.

33. Human papillomavirus and vaccination.

Author: Huang CM;
Institution: Department of Internal Medicine, UCLA School of Medicine, VA Greater Los Angeles Healthcare System, West Los Angeles, California. 11301 Wilshire Blvd (PACC), Los Angeles, CA 90073, USA.
Journal: Mayo Clin Proc. 2008 Jun;83(6):701-6; quiz 706-7.
Abstract URL: Click here to view abstract

34. Patients with locally advanced cervical cancer should not undergo routine pretreatment surgical staging.

Author: Mota F; De Oliveira C;
Institution: Department of Gynaecology, University Hospital of Coimbra, Portugal.
Journal: Eur J Gynaecol Oncol. 2006;27(2):109-14.
Abstract URL: Click here to view abstract

35. Cervical cancer.

Author: Moore DH;
Institution: Department of Gynecologic Oncology, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA. dhmoore@iupui.edu
Journal: Obstet Gynecol. 2006 May;107(5):1152-61.
Abstract URL: Click here to view abstract

36. Concurrent chemotherapy and radiation therapy as the standard of care for cervical cancer.

Author: Eifel PJ;
Institution: The University of Texas MD Anderson Cancer Center, Department of Radiation Oncology, 1515 Holcombe Boulevard, Unit 1202, Houston, TX 77030, USA. peifel@mdanderson.org
Journal: Nat Clin Pract Oncol. 2006 May;3(5):248-55.
Abstract URL: Click here to view abstract

37. Management of cervical cancer.

Author: Kesic V;
Institution: Institute of Obstetrics and Gynecology, Clinical Center of Serbia, Visegradska 26, 11000 Belgrade, Serbia and Montenegro. vek@eunet.yu <vek@eunet.yu>
Journal: Eur J Surg Oncol. 2006 Oct;32(8):832-7. Epub 2006 May 12.
Abstract URL: Click here to view abstract

38. A critical review of patient-rated quality of life studies of long-term survivors of cervical cancer.

Author: Vistad I; Fossa SD; Dahl AA;
Institution: Department of Gynecology, Sorlandet Hospital HF, Kristiansand, Norway. ingvild.vistad@sshf.no
Journal: Gynecol Oncol. 2006 Sep;102(3):563-72. Epub 2006 May 22.
Abstract URL: Click here to view abstract

39. Future fertility after conservation surgery for cervical cancer.

Author: Farthing A;
Institution: West London Gynaecological Cancer Centre, Queen Charlottes Hospital, London W12 0HS.
Journal: Br J Hosp Med (Lond). 2006 May;67(5):250-2.
Abstract URL: Click here to view abstract

40. Fertility-preserving options for cervical cancer.

Author: Plante M; Roy M;
Institution: Gynecologic Oncology Service, Laval University, Quebec, Canada. marie.plante@crhdq.ulaval.ca
Journal: Oncology (Williston Park). 2006 Apr;20(5):479-88; discussion 491-3.
Abstract URL: Click here to view abstract

41. Cervical cancer: radiotherapy and hyperthermia.

Author: van der Zee J; van Rhoon GC;
Institution: Department of Radiation Oncology, Hyperthermia Unit, Rotterdam, The Netherlands. j.vanderzee@erasmusmc.nl
Journal: Int J Hyperthermia. 2006 May;22(3):229-34.
Abstract URL: Click here to view abstract

42. Long-term risk of invasive cervical cancer after treatment of squamous cervical intraepithelial neoplasia.

Author: Soutter WP; Sasieni P; Panoskaltsis T;
Institution: Imperial College, Hammersmith Hospital Campus, London, United Kingdom. p.soutter@imperial.ac.uk
Journal: Int J Cancer. 2006 Apr 15;118(8):2048-55.
Abstract URL: Click here to view abstract

43. Risk of second cancers after radiotherapy for cervical cancer.

Author: Ohno T; Kakinuma S; Kato S; Tsujii H; Shimada Y;
Institution: Research Center for Charged Particle Therapy, National Institute of Radiological Sciences, 4-9-1 Anagawa, Chiba, Japan. t_ohno@nirs.go.jp
Journal: Expert Rev Anticancer Ther. 2006 Jan;6(1):49-57.
Abstract URL: Click here to view abstract

44. Chemoprevention of cervical cancer.

Author: Sasieni P;
Institution: Cancer Research UK Centre for Epidemiology, Mathematics and Statistics, Wolfson Institute of Preventive Medicine, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK. peter.sasieni@cancer.org.uk
Journal: Best Pract Res Clin Obstet Gynaecol. 2006 Apr;20(2):295-305. Epub 2006 Jan 4.
Abstract URL: Click here to view abstract

45. Vaccines for cervical cancer.

Author: Lowndes CM;
Institution
Journal: Epidemiol Infect. 2006 Feb;134(1):1-12.

46. Cervical cancer screening in older women.

Author: Dallred C;
Institution: Department of Nursing Professional Development and Education, University of Texas M.D. Anderson Cancer Center, Houston, USA. csdallre@mdanderson.org
Journal: Clin J Oncol Nurs. 2006 Feb;10(1):31-3.

47. A systematic review of postcoital bleeding and risk of cervical cancer.

Author: Shapley M; Jordan J; Croft PR;
Institution: Primary Care Sciences Research Centre, Keele University, Staffordshire. m.shapley@cphc.keele.ac.uk
Journal: Br J Gen Pract. 2006 Jun;56(527):453-60.
Abstract URL: Click here to view abstract

48. Effects of different chemotherapy regimens on survival for advanced cervical cancer: systematic review and meta-analysis.

Author: Tzioras S; Pavlidis N; Paraskevaidis E; Ioannidis JP;
Institution: Department of Obstetrics and Gynaecology, University of Ioannina School of Medicine, Ioannina, Greece.
Journal: Cancer Treat Rev. 2007 Feb;33(1):24-38. Epub 2006 Nov 16.
Abstract URL: Click here to view abstract

49. Overview of cervical cancer in the developing world. FIGO 6th Annual Report on the Results of Treatment in Gynecological Cancer.

Author: Sankaranarayanan R;
Institution: Head, Screening Group, World Health Organization - International Agency for Research on Cancer, Lyon 69008, France. sankar@iarc.fr
Journal: Int J Gynaecol Obstet. 2006 Nov;95 Suppl 1:S205-10.

50. HPV DNA testing for cervical cancer screening. FIGO 6th Annual Report on the Results of Treatment in Gynecological Cancer.

Author: Wright TC Jr;
Institution: Department of Pathology, Columbia University, New York, USA. tcw1columbia.edu
Journal: Int J Gynaecol Obstet. 2006 Nov;95 Suppl 1:S239-46.

51. Human papillomavirus vaccines for the treatment of cervical cancer.

Author: Sin JI;
Institution: Catholic University of Daegu, Department of Microbiology, School of Medicine, 3056-6, Daemyung-4-Dong, Namgu, Daegu, 705-718, Korea. jsin1964@hanmail.net
Journal: Expert Rev Vaccines. 2006 Dec;5(6):783-92.
Abstract URL: Click here to view abstract

52. Chemoradiotherapy in the treatment of cervical cancer.

Author: Eifel PJ;
Institution: Department of Radiation Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA. peifel@mdanderson.org
Journal: Semin Radiat Oncol. 2006 Jul;16(3):177-85.
Abstract URL: Click here to view abstract

53. Current controversies in high-dose-rate versus low-dose-rate brachytherapy for cervical cancer.

Author: Stewart AJ; Viswanathan AN;
Institution: Department of Radiation Oncology, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA.
Journal: Cancer. 2006 Sep 1;107(5):908-15.
Abstract URL: Click here to view abstract

54. Cervical cancer: what should we tell women about screening?

Author: Tiffen J; Mahon SM;
Institution: Department of Medical-Surgical Nursing, University of Illinois-Chicago, USA. jtiffen@uic.edu
Journal: Clin J Oncol Nurs. 2006 Aug;10(4):527-31.
Abstract URL: Click here to view abstract

55. Cervical cancer screening today. The role of HPV DNA testing.

Author: Berman NR;
Institution: Northwest Internal Medicine Associates, Southfield, Michigan, USA.
Journal: Adv Nurse Pract. 2006 Apr;14(4):24-9; quiz 30.

56. American Cancer Society Guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors.

Author: Saslow D; Castle PE; Cox JT; Davey DD; Einstein MH; Ferris DG; Goldie SJ; Harper DM; Kinney W; Moscicki AB; Noller KL; Wheeler CM; Ades T; Andrews KS; Doroshenk MK; Kahn KG; Schmidt C; Shafey O; Smith RA; Partridge EE; Garcia F;
Institution: Cancer Control Science Department, American Cancer Society, Altanta, GA, USA.
Journal: CA Cancer J Clin. 2007 Jan-Feb;57(1):7-28.
Abstract URL: Click here to view abstract